Open Science momentum grows stronger in Canada with a new commitment by its largest mental health teaching hospital
The Centre for Addiction and Mental Health (CAMH) joins the Tanenbaum Open Science Institute alliance in a partnership to open research practicesThe Centre for Addiction and Mental Health (CAMH), Canada’s largest mental health teaching hospital in the country is pleased to announce that it has entered into a partnership with the Tanenbaum Open Science Institute (TOSI) at McGill University
New digital consent platform streamlines consent process
Partnership with Novartis Pharmaceuticals Canada Inc. has created a faster, easier way for patients to contribute to research
$6M grant for new Open Science patient registry
Goal is to accelerate research and let patients know how their data is helping find treatmentsA $6M grant from Brain Canada will fund the creation of a new Open Science patient registry, to share data with researchers around the world and let patients see how their data is used to develop new treatments for neurological disorders.
Changing how we value research
The Neuro joins two other McGill-affiliated organizations in signing The Declaration on Research AssessmentThe Neuro (Montreal Neurological Institute-Hospital) has joined the Douglas Research Centre (DRC) and the Canadian Open Neuroscience Platform (CONP) in signing the San Francisco Declaration on Research Assessment (DORA), an agreement that seeks to change how scholarly research contributions are valued in hiring, promotion, and funding decisions.
Douglas Research Centre joins The Neuro in Open Science
Five-point strategy will maximize the impact of research and maintain leadership in mental health research and careToday the Douglas Research Centre (DRC) joins The Neuro’s Tanenbaum Open Science Institute (TOSI) as a partner in research data sharing and collaboration through the adoption of a set of institutional Open Science principles.
Open Science antibody characterization project receives $4-million grant
YCharOS is an independent quality assessment initiative to improve research resultsAn antibody characterization project with partners at The Neuro will be able to expand thanks to funding from Génome Québec.
Neuro Genomics Partnership aims to drive neurological disease research
Academia and industry collaborate to find new targets for neurological disease treatmentA new research collaboration between The Neuro (Montreal Neurological Institute-Hospital), Takeda Development Center Americas, Inc. and Roche will enable large-scale analysis of patient data to potentially find promising targets for drug development in neurological diseases.
Open science – reflecting upon real-world impact
To support 2021’s International Open Access Week, Pfizer commissioned Inspiring STEM Consulting to record a series of podcast interviews with experts working within clinical and medical disciplines.
Fueled by philanthropy and institutional partnerships, Open Science grows stronger in Canada
The Tanenbaum Open Science Institute (TOSI) at The Neuro welcomes the Hotchkiss Brain Institute as a new partner to transform brain research through Open ScienceDiseases of the brain are among the most complex to understand and difficult to treat. Traditional research practices aren’t always sufficient to produce truly effective and novel treatments for most neurological diseases.
YCharOS forms key industry advisory committee and releases first open data
Leading antibody reagent and knockout cell line manufacturers team up to address life science reproducibility crisis
YCharOS Inc., an open science company with the mission of characterizing commercially available antibody reagents for all human proteins, is pleased to announce the publication of its first characterization data and formation of its Industry Advisory Committee (IAC).
Big data analysis suggests role of brain connectivity in epilepsy-related atrophy
Large multi-site study accurately predicts damage to grey matter by disease
An international study has found a link between the brain’s network connections and grey matter atrophy caused by certain types of epilepsy, a major step forward in our understanding of the disease.
The Neuro Supports the Open COVID Pledge
The Neuro proudly supports the Open COVID Pledge, which calls on academic institutions, industry, and other organizations to make their intellectual property available free of charge for use in ending the COVID-19 pandemic and minimizing its impact.
Gairdner Foundation recognizes Dr. Guy Rouleau with prestigious award
The Neuro’s director has been a driving force in neurological disease research and Open Science leadership
$1M donation to support autism research powered by open science
Djavad Mowafaghian Foundation shares The Neuro’s open science vision to accelerate drug discovery and find new and effective treatments for autism spectrum disorders
The Neuro and Thermo Fisher Scientific Partner to Fight Neurodegenerative Disease
Industry and academia to share expertise in effort to develop improved methods to produce and characterize antibodies and reagents for neurological research
